feed,title,long_url,short_url
Investors,Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy,https://www.investors.com/news/technology/sarepta-stock-expanded-approval-elevidys-duchenne-muscular-dystrophy-gene-therapy/,https://da.gd/YkTxx
